Jade Biosciences (JBIO) Other financing activities (2022 - 2026)

Jade Biosciences (JBIO) has 5 years of Other financing activities data on file, last reported at $45000.0 in Q1 2026.

• Quarterly Other financing activities changed N/A year-over-year to $45000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$190.1 million (changed N/A YoY) and the FY2025 annual result came in at $296000.0, down 3.9% from the prior year.
• Other financing activities advanced to $45000.0 in Q1 2026, from -$190.2 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $704000.0 in Q1 2024 to a low of -$190.2 million in Q4 2025.
• A 5-year average of -$18.9 million and a median of $86500.0 in 2023 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 633.33% in 2023, down 290.7% in 2023.
• Tracing JBIO's Other financing activities over 5 years: stood at -$24000.0 in 2022, then surged by 633.33% to $128000.0 in 2023, then slumped by 409.38% to -$396000.0 in 2024, then tumbled by 47919.19% to -$190.2 million in 2025, then surged by 100.02% to $45000.0 in 2026.
• The last three Other financing activities figures came in at $45000.0 (Q1 2026), -$190.2 million (Q4 2025), and -$396000.0 (Q2 2024), per Business Quant data.